Replies to post #1220 on Conatus Pharmaceuticals Inc. (CNAT)

[bleu22]

Nice pre ER RUN UP

[realfast95]

This isn't news
but news to me.

One of those news sites that repeat stuff

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) – Analysts at FBR & Co raised their FY2019 EPS estimates for shares of Conatus Pharmaceuticals in a research note issued to investors on Monday. FBR & Co analyst V. Bernardino now expects that the brokerage will earn $3.07 per share for the year, up from their previous forecast of $2.97. FBR & Co has a “Outperform” rating and a $16.00 price target on the stock. FBR & Co also issued estimates for Conatus Pharmaceuticals’ FY2020 earnings at $2.57 EPS and FY2021 earnings at $2.98 EPS.


https://baseballnewssource.com/markets/conatus-pharmaceuticals-inc-cnat-expected-to-post-fy2019-earnings-of-3-07-per-share/524762.html